Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.
Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe website has posted new results on the effectiveness and safety of Pembrolizumab and Rituximab, including updated primary and secondary outcome measures, while removing previous submissions and details related to patient response rates and quality of life assessments.SummaryDifference15%
- Check33 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check41 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.2%
- Check62 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check70 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference1%
Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.